Posts tagged OLO
Sight Diagnostics chooses bioaccess™ as regulatory consultant to sell an AI-based diagnostics device for faster blood tests in Colombia
Sight Diagnostics chooses bioaccess™ as regulatory consultant to sell an AI-based diagnostics device for faster blood tests in Colombia

Israel-based Sight Diagnostics has chosen bioaccess™ as its regulatory and market access partner to obtain marketing authorization towards the commercialization of its innovative point-of-care blood diagnostic device, OLO. The OLO device uses artificial intelligence (AI) to optically read small amounts of blood and provide complete blood count tests during a single doctor’s visit. In 2018, Sight Diagnostics received its CE mark and begun selling its OLO device in Europe and other countries.

Read More
Product Registration, Regulatory Consulting, Market AccessJulio G. Martinez-ClarkSight Diagnostics, OLOComment